Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer
Birendra Kumar Sah(Ruijin Hospital), Chao Yan(Shanghai Jiao Tong University), Zhenggang Zhu(Wuhan Center for Disease Control and Prevention), Min Yan(Zhengzhou University), Fei Yuan(Shanghai Jiao Tong University), Bingya Liu(Shanghai Jiao Tong University), Wei Xu(Second Military Medical University), Huan Zhang(East China University of Science and Technology), Jian Li(Guizhou University), Wentao Liu(Institute of Metal Research), Min Shi(Hebei Medical University), Benyan Zhang(Shanghai Jiao Tong University), Zhenglun Zhu(Brigham and Women's Hospital), Tao Ma(Ningbo Medical Center Lihuili Hospital)
Cited by 121
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
|Oncotarget|2017|400
miR-126 functions as a tumour suppressor in human gastric cancer
|Cancer Letters|2010|298
CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway
|Journal of Experimental & Clinical Cancer Research|2019|231
A Nanocomposite Hydrogel with Potent and Broad-Spectrum Antibacterial Activity
|ACS Applied Materials & Interfaces|2018|215